Age-specific occurrence of HPV16- and HPV18-related cervical cancer. - Test2 - elhamkhani - TriplyDB

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

http://www.wikidata.org/entity/Q35013844

about

Age-specific prevalence of HPV16/18 genotypes in cervical cancer: A systematic review and meta-analysis.US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.Prophylactic HPV vaccination: past, present, and future.Assessment of the Effectiveness of HPV16/18 Infection Referred for Colposcopy in Cervical Cancer Screening in Northwest of China.HPV status and favourable outcome in vulvar squamous cancer.HPV genotype distribution in older Danish women undergoing surgery due to cervical cancer.Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline.miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-βRI signaling pathway.Comparative Cost-Effectiveness Analysis of Two Different Two-Dose Human Papillomavirus Vaccines in Malaysia

P2860

Q30252012-93B0A464-2855-4E7C-95FC-F01AB61F5641 Q36817074-F1A587CF-4D24-4FFE-807C-7AA41EE1F56E Q38373388-AC66ABF6-0523-4B90-92CB-A1C561988B92 Q38597567-200DBEC5-F60D-4F1F-A940-52B94F08ED1F Q40133840-E41CAF47-FCDC-49AA-BE7F-939EC40F0484 Q40444484-D5112A69-BF1D-4BB6-96A4-232070A00255 Q41037128-17518DBD-4D50-4CE4-980E-71F69799D5A5 Q42690821-4E71FFEF-478F-4178-AF08-33E1EFD38EEC Q43924111-C1E92D89-3EBD-466B-9298-7B35426BF2AA Q44841725-3F2FD933-6CE2-4CEF-89DE-96DAD04035BA Q47111040-B62EEBBC-F93F-4828-A330-98487CAD5CB4 Q52659539-83234635-69AC-4BAF-8D36-E85E740F1F4F Q55540751-2E173A26-A5E2-4A59-BDAB-4448F3415E29

P2860

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

http://www.wikidata.org/entity/Q35013844

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

@ast

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

@en

type

label

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

@ast

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

@en

prefLabel

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

@ast

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

@en

P1433

Q35013844-71FAB906-4DBF-483A-84C4-6036D8668782

P1476

Q35013844-AA670FC8-C525-4D11-99B7-5553CC78AE33

P2093

Q35013844-27EB8D57-DA4F-4A60-8CDD-74D5B76AE96F

Q35013844-3652720F-7ED8-4A3D-B48A-D53512C0DF3E

Q35013844-3DB00422-A0FF-4575-9B84-1FF748C670B2

Q35013844-40FB3EFF-297E-4340-ABC1-BF95AE3D4FD3

Q35013844-4123E107-71F7-467D-B7AE-23F11E62A746

Q35013844-80D889E2-1B3A-40A2-BEB2-594511144E47

Q35013844-88A7571B-A93D-43E2-A014-0A6DD1271680

Q35013844-91D2FCA0-0DBB-4300-88E0-226C5A1D7AAA

Q35013844-E6ECAC6B-B5EC-49D3-89AE-6E076685B72C

P2860

Q35013844-0677AA05-91DB-419A-9A01-68339CE604BF

Q35013844-1CB25D8B-53C3-4507-833A-FA02769CF197

Q35013844-3605DB10-3979-447E-99D1-DA57792FE0DD

Q35013844-4A5A2AFB-58A1-43CE-A791-C4363C70F83A

Q35013844-56AD64F5-3EBE-472C-B420-7EE44C701972

Q35013844-5AF236A0-8FCB-4D57-B564-9F01EADCFEF1

Q35013844-6D8C66FB-1ECF-4A1A-9A4B-4B7D2CFB6CD2

Q35013844-755438BA-423D-4B23-85F6-95AC7FA5C36B

Q35013844-7C348479-DDAA-45D5-9D53-410E499430EA

Q35013844-8490122F-F3A0-4C2E-90F3-95AF070D75B2

P304

Q35013844-29DA6768-1A3F-4C90-A74A-B6A4DEC3592F

P31

Q35013844-23E2B877-DDAD-4AF8-BDD1-87F3B06AF8EB

P356

Q35013844-CCA137C5-7FEB-4DDA-89D1-7A3CA0DB0977

P433

Q35013844-084A9633-9292-4B7A-B611-6AB2ADC39BCA

P478

Q35013844-E738E1FF-D072-4642-A5B1-7AF6F975A22C

P50

Q35013844-0B03DE74-AAB4-448B-ACAC-27DCA9F32F8F

Q35013844-EF2B51CF-F973-40E2-B725-49412C70FC8A

P577

Q35013844-F256968A-F571-4179-A1B2-0FC27F839C46

P5875

Q35013844-A40F1AD0-045E-4A9F-AA60-D55BD9AB99F0

P698

Q35013844-7BB29DAF-E132-40C2-8455-8A59CFEC0CA2

P932

Q35013844-EA5DE25E-8262-46A6-BEDB-BFCDE1556C7B

P356

1055-9965.EPI-13-0053

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

@en

P2093

Evan R Myers

http://www.w3.org/2001/XMLSchema#string

F Xavier Bosch

http://www.w3.org/2001/XMLSchema#string

Laia Alemany

http://www.w3.org/2001/XMLSchema#string

Nancy E Joste

http://www.w3.org/2001/XMLSchema#string

Philip E Castle

http://www.w3.org/2001/XMLSchema#string

Retrospective International Survey and HPV Time Trends Study Group

http://www.w3.org/2001/XMLSchema#string

Silvia de Sanjose

http://www.w3.org/2001/XMLSchema#string

William C Hunt

http://www.w3.org/2001/XMLSchema#string

Wim G V Quint

http://www.w3.org/2001/XMLSchema#string

P2860

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Recommendations on screening for cervical cancer

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Cervical carcinoma rates among young females in the United States.

P304

1313-1318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-13-0053

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Silvia de Sanjosé

Cosette M Wheeler

P577

2013-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236599517

http://www.w3.org/2001/XMLSchema#string

P698

23632816

http://www.w3.org/2001/XMLSchema#string

P932

4306595

http://www.w3.org/2001/XMLSchema#string